Narrow Results

Progen and Avexa Agree to Merge for Research Synergies

Merial to Develop Vaccine Candidates Using Imugene's Vector Technology

Mesoblast Named as Emerging Company to Look Out For at 2009 Frost & Sullivan Award

Joint Laboratory by ProGenTech and China CDC

BIG Taps Life Technologies' SOLiD System to Advance Research in China

Thermo Fisher Scientific Launches Program to Meet Melamine Detection Challenges

The Sym006 Discovery Collaboration of Symphogen and Meiji Advanced to Preclinical Development

Astellas Enters License Agreement to Use Millipore's Technology

S*BIO and Tan Tock Seng Hospital to Assess New Therapeutic

Preclinical Translational Imaging Center Opened in Singapore

KKH Implements Rapid HIV Testing for Unbooked Pregnancies

Singapore's Parkway Chosen to Manage Abu Dhabi Hospital

The provision of central resources of human stem cell lines will be an important element in enabling progress in stem cell research and the development of safe and effective cell therapies. These resource centres, commonly referred to as "stem cell banks", could promote advances in the field of stem cell research, by providing access to well-characterised and quality controlled seed stocks of human stem cell lines that have been checked for appropriate ethical provenance. Such banks can also deliver benefits for the field through establishing international collaboration and standardisation between the developing national stem cell banking centres. This chapter will review the key issues that centres banking and distributing stem cells must address to support the research community in the development of exciting cell therapies for the future.